Abstract
Infection with hepatitis C virus (HCV) is a major cause of transfusion-associated hepatitis, cirrhosis and hepatocellular carcinoma. The present study was conducted with an objective to evaluate the prevalence of anti-HCV antibody in New Delhi, India using a large number of healthy voluntary blood donors. A total of 15,898 healthy voluntary blood donors were subjected to anti-HCV testing (using a commercially available third generation anti-HCV ELISA kit) and 249 were found to be reactive for anti-HCV antibody, yielding an overall prevalence of 1.57%. No significant difference was found between the HCV positivity rate of male (1.57%; 238/15,152) vs. female (1.47%; 11/746) donors, family (1.58%; 213/13,521) vs. altruistic (1.51%; 36/2377) donors and first-time (1.55%; 180/11,605) vs. repeat (1.61%; 69/4293) donors. The age distribution of anti-HCV reactivity showed a maximum prevalence rate of 1.8% in the age group of 20–29 years. In addition, there was a clear trend of decreasing positivity for anti-HCV with increasing age and this trend was statistically significant. The results of the present study show that the prevalence of anti-HCV antibodies in the healthy voluntary blood donors of New Delhi, India is considerably higher than the reported seroprevalence of HCV in majority of the industrialized nations and this represents a large reservoir of infection capable of inflicting significant disease burden on the society. In addition, donors of New Delhi, India showed a trend of decreasing seroprevalence with increasing age, possibly implying a higher exposure rate to HCV in younger subjects.
Similar content being viewed by others
References
Choo QL, Weiner AJ, Overby LR, et al. Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46: 423–441.
Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362.
Makroo RN, Raina V, Kaushik V. Prevalence of hepatitis C virus antibody in healthy blood donors. Indian J Med Res 1999; 110: 123–125.
Panigrahi AK, Panda SK, Dixit RK, et al. Magnitude of hepatitis C virus infection in India: Prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997; 51: 167–174.
Sherlock S, Dooley J. Hepatitis C virus. In: Disease of the Liver and the Biliary System. 9th ed. Blackwell Scientific Publications, 1993; 283–287.
van der Poel CL, Reesink HW, Schaasberg W, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990; 335: 558–560.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jain, A., Rana, S., Chakravarty, P. et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol 18, 695–698 (2003). https://doi.org/10.1023/A:1024887211146
Issue Date:
DOI: https://doi.org/10.1023/A:1024887211146